RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 156 filers reported holding RELAY THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,102,500 | -33.0% | 250,000 | 0.0% | 0.02% | -32.4% |
| Q2 2023 | $3,140,000 | -30.7% | 250,000 | -9.1% | 0.04% | -40.3% |
| Q1 2023 | $4,529,250 | -8.6% | 275,000 | -17.1% | 0.06% | -6.1% |
| Q4 2022 | $4,955,045 | -33.2% | 331,663 | 0.0% | 0.07% | -36.5% |
| Q3 2022 | $7,419,000 | +33.6% | 331,663 | 0.0% | 0.10% | +20.9% |
| Q2 2022 | $5,555,000 | -44.0% | 331,663 | 0.0% | 0.09% | -46.6% |
| Q1 2022 | $9,927,000 | +26.5% | 331,663 | +29.8% | 0.16% | +43.8% |
| Q4 2021 | $7,850,000 | -2.6% | 255,601 | 0.0% | 0.11% | -15.2% |
| Q3 2021 | $8,059,000 | -23.7% | 255,601 | -11.4% | 0.13% | -33.0% |
| Q2 2021 | $10,558,000 | +28.1% | 288,557 | +21.0% | 0.20% | +7.7% |
| Q1 2021 | $8,243,000 | -32.4% | 238,440 | -18.7% | 0.18% | -43.3% |
| Q4 2020 | $12,186,000 | -18.7% | 293,215 | -16.7% | 0.32% | -34.2% |
| Q3 2020 | $14,984,000 | – | 351,823 | – | 0.49% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Grace Capital | 183,112 | $5,665,000 | 3.48% |
| Casdin Capital, LLC | 3,668,574 | $115,670,000 | 2.88% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $879,843,000 | 2.73% |
| BVF INC/IL | 2,049,113 | $64,609,000 | 2.52% |
| Fernwood Investment Management, LLC | 185,063 | $5,835,000 | 2.00% |
| EcoR1 Capital, LLC | 1,385,276 | $43,678,000 | 1.52% |
| Boxer Capital, LLC | 1,294,132 | $40,804,000 | 1.42% |
| Integral Health Asset Management, LLC | 140,000 | $4,414,000 | 1.27% |
| Alphabet Inc. | 1,641,497 | $51,756,000 | 1.23% |
| Bellevue Group AG | 3,755,962 | $118,426,000 | 1.20% |